Cedazuridine, Decitabine

Inqovi

100 MG + 35 MG TabletCanadaMarketedAuthorised 11 Nov 2020

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

InqoviUnited States · 100MG; 35MG · tablet · Taiho OncologySame brand
Inaqovi 35 MG/100 MG Comprimidos Recubiertos con PeliculaSpain · 35 mg + 100 mg · comprimido recubierto con película · Otsuka Pharmaceutical Netherlands B.V.Same form
InaqoviItaly · Compressa rivestita con film · Otsuka Pharmaceutical Netherlands BVSame form
Inaqovi 35 mg/100, fimomhulde tablettenNetherlands · Filmomhulde tablet · Otsuka Pharmaceutical Netherlands B.V.Same form
InaqoviEuropean Union · Otsuka Pharmaceutical Netherlands B.V.Same substance
InaqoviCroatiaSame substance

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Cedazuridine, Decitabine

Inqovi

100 MG + 35 MG TabletCanadaMarketedAuthorised 11 Nov 2020

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Cedazuridine, Decitabine
Strength: 100 MG + 35 MG
Dosage form: Tablet
Route: Oral
Register: Canada (Health Canada)
Status: Marketed
Authorised: 11 Nov 2020
Registration: DIN 02501600
Marketing authorisation holder: Taiho Pharma Canada, INC.
ATC code: L01BC58
Group: Antineoplastic and immunomodulating agents
Supply: PRESCRIPTION